The opioid crisis has grown to affect pregnant women and infants across the United States,
as evidenced by rising rates of opioid use disorder among pregnant women and neonatal …

Neonatal abstinence syndrome (NAS) is a result of the sudden discontinuation of fetal
exposure to substances that were used or abused by the mother during pregnancy …

Background Although clinicians have traditionally used the Finnegan Neonatal Abstinence
Scoring Tool to assess the severity of neonatal opioid withdrawal, a newer function-based …

Objective: Neonatal abstinence syndrome (NAS), a postnatal opioid withdrawal syndrome,
increased threefold from 2000 to 2009. Since 2009, opioid pain reliever prescriptions and …

Background The incidence of the neonatal abstinence syndrome, a drug-withdrawal
syndrome that most commonly occurs after in utero exposure to opioids, is known to have …

Prenatal substance use is a critical public health concern that is linked with several harmful
maternal and fetal consequences. The most frequently used substance in pregnancy is …

Neonatal Abstinence Syndrome | NEJM Skip to main content NEJM Group Follow Us Facebook
Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge …

Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome in newborns
caused primarily by in utero exposure to opioids. In the United States, the incidence of NAS …

Preconception and prenatal exposure to environmental contaminants may affect future
health. Pregnancy and early life are critical sensitive windows of susceptibility. The aim of …

Objective The objective of the study was to provide national prevalence, patterns, and
correlates of marijuana use in the past month and past 2–12 months among women of …